Incyte | 8-K: Current report
Incyte | 8-K: Current report
Incyte | DEFA14A: Others
Incyte | 8-K: Current report
Incyte | 8-K: Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | DEFA14A: Others
Incyte | DEF 14A: Definitive information statements
Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Incyte | 8-K: Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Incyte | 8-K: Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 8-K: Current report
Incyte | 8-K: Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Incyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Incyte | 8-K: Current report
Incyte | DEFA14A: Others
Incyte | 8-K: Current report
Incyte | 8-K: Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | DEFA14A: Others
Incyte | DEF 14A: Definitive proxy statements
No Data